Skip to the menu
Account Cart 0
Guides

CBG vs. CBD: one parent molecule, two very different research records

CBG's acid is the raw material the plant turns into CBD's. CBD has an FDA-approved drug and agency safety warnings; CBG has neither. How each is made, what is and is not established, and where both stand under federal law from Dec. 11, 2026.

Historic photograph of workers spreading hemp in a Kentucky field
Historic photograph of workers spreading hemp in a Kentucky field. File photo.

See today's flower Shipping is free on every order.

The short answer. The plant turns CBG’s acid into CBD’s. NIDA says CBD is not intoxicating; a small 2024 trial found no subjective drug effects from 20 mg of CBG. CBD has an FDA-approved drug and FDA safety warnings; CBG has neither. As of Oct. 13, 2026, both stay hemp after Dec. 11, 2026 only within new THC limits.

Health facts on this page come only from the FDA, the National Institute on Drug Abuse (NIDA), NIH’s NCCIH and research indexed in NIH’s PubMed. The THC side of the family is in THC vs. CBD and THCA vs. CBD.

What is the difference between CBG and CBD?

CBG (cannabigerol) CBD (cannabidiol)
Formula C21H32O2, 316.5 g/mol (PubChem) C21H30O2, 314.5 g/mol (PubChem)
Acid form in the plant CBGA, C22H32O4 (PubChem) CBDA, C22H30O4 (PubChem)
Where it sits in the plant’s chemistry First: CBGA is the parent acid Second: made from CBGA by CBDA synthase
Intoxicating One small 2024 trial found no drug high (Cuttler and others) No: “not intoxicating like THC” (NIDA)
FDA-approved drugs None Epidiolex, for certain seizure disorders (FDA)
FDA safety warnings None issued that we found Liver injury, drug interactions, drowsiness, diarrhea (FDA)
Human research Thin: “little research has been performed” (2021 review) FDA-reviewed trials behind Epidiolex
Federal status, Oct. 13, 2026 Not a controlled substance when from hemp Not a controlled substance when from hemp; FDA bars it from food and supplements
From Dec. 11, 2026 Hemp only if total THC is within the new limits Hemp only if total THC is within the new limits

The two molecules differ by two hydrogen atoms and by shape: CBG keeps an open geranyl chain, which CBDA synthase closes into a second ring by “oxidocyclization” (Taura and others, 1996). They are not interchangeable, and evidence about one does not carry over to the other.

How does the plant make CBG and CBD?

In three steps:

  1. CBGA is built. An enzyme, geranylpyrophosphate:olivetolate geranyltransferase, joins olivetolic acid to geranyl pyrophosphate. German researchers described it in 1998 as “the first enzyme in the biosynthesis of cannabinoids,” and its product, cannabigerolic acid, as “the precursor of tetrahydrocannabinol” (Fellermeier and Zenk, 1998).
  2. CBGA is converted. CBDA synthase turns CBGA into CBDA (Taura and others, 1996). THCA synthase turns the same CBGA into THCA, and works in the storage cavity of the glandular trichomes (Sirikantaramas and others, 2005). Which enzyme the plant’s genes favor decides whether the flower is THCA-rich, CBDA-rich or a mix.
  3. Heat finishes the job. Heating removes the acid’s carboxyl group: CBGA becomes CBG, CBDA becomes CBD, THCA becomes delta-9 THC.

Because most CBGA is used up in step 2, CBG-rich flower needs plants that keep it. Researchers documented and studied the inheritance of such “cannabigerol predominant plants” in 2005 (de Meijer and Hammond, Euphytica). On a lab report, each cannabinoid gets an acid line and a neutral line; our COA guide shows how the totals are calculated.

Does CBG get you high?

For CBD, NIDA is direct: “CBD is not intoxicating like THC.” For CBG, no federal agency page we checked says either way. NIDA’s own list of “intoxicating cannabinoids and related compounds” with limited research names delta-8 THC, delta-10 THC, THCV, THCP, HHC and CBN, among others; CBG is not on it. How CBN, the one on that list that forms as THC ages, compares with CBD is set out in CBN vs. CBD.

The human evidence is one small study. In a 2024 double-blind, placebo-controlled crossover trial, 34 healthy adults took 20 mg of hemp-derived CBG or a placebo tincture; the researchers found “no evidence of subjective drug effects or impairment” (Cuttler and others, Scientific Reports, 2024). One trial at one oral dose is not a safety finding, and it says nothing about smoked flower or larger amounts.

The 2021 review in the Journal of Pharmacology and Experimental Therapeutics explains why the question is open: CBG “exhibits affinity and activity characteristics between Δ9-THC and CBD at the cannabinoid receptors” (Nachnani and others, 2021).

What do the FDA, NIH and NIDA say about CBG and CBD?

About CBD, a good deal. The FDA has approved one CBD drug, Epidiolex, for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome or tuberous sclerosis complex. Its consumer page warns that “CBD can cause liver injury” and can interact with other medicines, and says “it is currently illegal to market CBD by adding it to a food or labeling it as a dietary supplement” (FDA). NIDA lists possible side effects including “drowsiness, decreased appetite, vomiting and diarrhea,” and says some products marketed as CBD have been found to contain THC. NCCIH says over-the-counter CBD may hold more or less CBD than its label states.

About CBG, nothing specific. None of those FDA, NIDA or NCCIH pages mentions CBG. The FDA says that “with the exception of Epidiolex, Marinol, and Syndros, no product containing cannabis or cannabis-derived compounds (either plant-based or synthetic) has been approved as safe and effective for use in any patient population,” so no CBG product is approved. NIDA puts the plant’s cannabinoids at “at least 125.”

The research that exists is indexed by NIH’s National Library of Medicine. The 2021 review’s summary: CBG is being marketed with many claims, but “unlike CBD, however, little research has been performed on this unregulated molecule” (Nachnani and others, 2021).

What is not established about CBG?

As of Oct. 13, 2026, the federal sources above establish none of the following:

  • Any medical use. No CBG product is FDA-approved, and this page makes no health claim for CBG or CBD.
  • A safety profile in people. Several of the FDA’s CBD warnings come from its review of Epidiolex; no comparable federal review exists for CBG.
  • Drug interactions. The FDA warns about them for CBD. For CBG, the agencies are silent, which is not the same as safe.
  • Label accuracy. NCCIH’s label warning is about CBD; we found no federal data on CBG product labels.

The FDA says consumer use of any CBD product “should always be discussed with a healthcare provider” (FDA).

As of Oct. 13, 2026, both are outside the Controlled Substances Act when they come from hemp. The act defines marijuana as “all parts of the plant Cannabis sativa L.” and every derivative of it, then excludes “hemp, as defined in section 1639o of title 7” (21 U.S.C. 802(16)). Until Dec. 10, 2026, hemp is cannabis with no more than 0.3 percent delta-9 THC on a dry-weight basis (7 U.S.C. 1639o). Schedule I lists “tetrahydrocannabinols” but names neither cannabigerol nor cannabidiol (21 CFR 1308.11).

The FDA’s food and supplement bar is a second, separate limit, and its consumer page states it for CBD.

What changes for CBG and CBD on Dec. 11, 2026?

Section 781 of P.L. 119-37 rewrites the hemp definition, and H.R. 6500 (P.L. 119-103), sec. 2019, holds most of it until Dec. 11, 2026 (P.L. 119-37; H.R. 6500, enrolled).

Federal hemp rule Until Dec. 10, 2026 From Dec. 11, 2026
What is measured Delta-9 THC only “Total tetrahydrocannabinols concentration (including tetrahydrocannabinolic acid)”
Limit for plant material 0.3% by dry weight 0.3% by dry weight
Cannabinoids made outside the plant Not addressed Excluded if “synthesized or manufactured outside the plant”
Limit for final products None in the definition 0.4 mg combined total THC, and THC-like cannabinoids named by HHS, per container

What that means for these two:

  • CBG and CBD themselves are not counted. The limits are on THC, THCA and cannabinoids that HHS finds have THC-like effects.
  • Their THC content is. A CBG or CBD flower or extract stays hemp only if its total THC, THCA included, fits the limits. The statute defines “intermediate” products but not “final” ones, so whether a jar of raw flower faces the 0.4 mg cap is unsettled; our 0.4 mg container limit explainer has the math.
  • How it was made matters. A CBG or CBD “synthesized or manufactured outside the plant” is excluded from hemp.

The law also told the FDA to publish lists of naturally occurring cannabinoids and of THC-like cannabinoids within 90 days of enactment; their status is logged on our Hemp Ban Tracker.

State law can be stricter than federal law. Our state-by-state legality hub links every State Page, for example Texas, each with its hemp rule and a dated source.

Sources

Reviewed Oct. 13, 2026. This explainer describes chemistry, research and law; it is not medical or legal advice.

Questions readers asked

What is the difference between CBG and CBD?

Both are cannabinoids of the cannabis plant. The plant makes CBGA first and converts most of it into other acids, including CBDA, which heat turns into CBD. CBD has an FDA-approved drug, Epidiolex, and FDA safety warnings; CBG has no approved drug and far less human research.

How does the plant make CBG and CBD?

An enzyme joins olivetolic acid and geranyl pyrophosphate into cannabigerolic acid, CBGA. CBDA synthase then turns CBGA into CBDA, and THCA synthase turns it into THCA. Heat removes the acid group, giving CBG from CBGA and CBD from CBDA. CBG-rich flower comes from plants bred to keep their CBGA.

Does CBG get you high?

The evidence is thin. NIDA says CBD is not intoxicating like THC; it does not address CBG. In one 2024 placebo-controlled trial of 34 healthy adults given 20 mg of hemp-derived CBG by mouth, researchers found no evidence of subjective drug effects or impairment.

What do the FDA, NIH and NIDA say about CBG and CBD?

The FDA has approved one CBD drug, Epidiolex, warns that CBD can cause liver injury and interact with other drugs, and says it is illegal to add CBD to food or sell it as a dietary supplement. NIDA lists CBD side effects. None of the FDA, NIDA or NCCIH pages we checked mentions CBG, and the FDA has approved no CBG product.

What is not established about CBG?

Whether it treats any condition, its safety profile in people, how it interacts with medicines, and how accurately CBG products are labeled. A 2021 review indexed by NIH's PubMed says little research has been done on CBG compared with CBD.

Are CBG and CBD legal under federal law?

As of Oct. 13, 2026, CBG and CBD from hemp fall outside the Controlled Substances Act, because its marijuana definition excludes hemp, and neither is named on Schedule I. The FDA separately says it is illegal to add CBD to food or market it as a dietary supplement.

What changes for CBG and CBD on Dec. 11, 2026?

Hemp will be measured by total THC, THCA included, at 0.3 percent of dry weight. Products with cannabinoids synthesized or manufactured outside the plant are excluded, and final products may hold no more than 0.4 mg of total THC per container. CBG and CBD stay hemp only within those limits, as of Oct. 13, 2026.

Is CBG or CBD legal in my state?

State law can be stricter than federal law. Each State Page on this site gives the state's rule for the hemp-retail lane with a dated source.

Spotted an error? Write to hello@thcagroup.com and we print the correction here.

Filed under Guides · How we work · Report an error